ID: ALA4169418

Max Phase: Preclinical

Molecular Formula: C20H13Cl2FN2O

Molecular Weight: 387.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOc1nc(-c2ccc(F)cc2)cc(-c2ccc(Cl)cc2Cl)c1C#N

Standard InChI:  InChI=1S/C20H13Cl2FN2O/c1-2-26-20-17(11-24)16(15-8-5-13(21)9-18(15)22)10-19(25-20)12-3-6-14(23)7-4-12/h3-10H,2H2,1H3

Standard InChI Key:  ARJGPGLNFRLVBC-UHFFFAOYSA-N

Associated Targets(non-human)

Trachea 112 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 387.24Molecular Weight (Monoisotopic): 386.0389AlogP: 6.13#Rotatable Bonds: 4
Polar Surface Area: 45.91Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.44CX LogD: 6.44
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -1.82

References

1. Soliman EA, Panda SS, Aziz MN, Shalaby EM, Mishriky N, Asaad FM, Girgis AS..  (2017)  Synthesis, molecular modeling studies and bronchodilation properties of nicotinonitrile containing-compounds.,  138  [PMID:28753516] [10.1016/j.ejmech.2017.07.025]

Source